BEONE MEDICINES LTD. (BEIGF) Capital expenditures 2016–2025
BEONE MEDICINES LTD. (BEIGF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$185.8MFY2025 · since FY2016: $23.5M → $185.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $185.8M | -62.3% |
| FY2024 | $492.7M | -12.3% |
| FY2023 | $561.9M | +72.7% |
| FY2022 | $325.4M | +23.8% |
| FY2021 | $262.9M | +123.8% |
| FY2020 | $117.5M | +31.1% |
| FY2019 | $89.6M | +27.5% |
| FY2018 | $70.3M | +51.6% |
| FY2017 | $46.4M | +97.3% |
| FY2016 | $23.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice